ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CRBU vs IMA // 10Y YIELD & FRED MACRO BETA

Caribou Biosciences Inc. (NASDAQ) VS. ImageneBio Inc. (NASDAQ) • 15-METRIC TALLY: CRBU 3 — IMA 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRBU VS. IMA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CRBU IMA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 11.70% -65.00% +76.70 CRBU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 1/9 +3.00 CRBU /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 27.5 38.6 -11.10 IMA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $47.7M $46.0M $1.7M CRBU /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CRBU REV IMA REV CRBU GROSS % IMA GROSS % CRBU FCF IMA FCF
FY 2025 $11.2M $800.0K — — -$112.4M -$47.8M
FY 2024 $10.0M $3.5M — — -$143.1M -$21.3M
FY 2023 $34.5M $9.2M — — -$93.3M -$79.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRBU // BETA —
IMA // BETA —